Selective blockade of serotonin2C receptor enhances Fos expression specifically in the striatum and the subthalamic nucleus within the basal ganglia

Neuroscience Letters

Volumn 469, Issue 2, 2010, Pages 251-255

  De Deurwaerdère, Philippe ^a   Le Moine, Catherine ^a   Chesselet, Marie Françoise ^b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Basal ganglia; c Fos expression; SB 243213; Serotonin2C antagonist; Serotonin2C receptors

Indexed keywords

ANIMALS; CORPUS STRIATUM; GLOBUS PALLIDUS; INDOLES; MALE; MIANSERIN; PHOTOMICROGRAPHY; PROTO-ONCOGENE PROTEINS C-FOS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN ANTAGONISTS; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

EID: 72749113015     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.12.006     Document Type: Article

References (39)

1. 2C receptors. Synapse 55 (2005) 242-251
2. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
3. Belforte J.E., and Pazo J.H. Turning behaviour induced by stimulation of the 5-HT receptors in the subthalamic nucleus. Eur. J. Neurosci. 19 (2004) 346-355
4. 2C receptor-mediated responses. J. Pharmaceut. Exp. Ther. 319 (2006) 260-268
5. Chen L., Yung K.K., Chan Y.S., and Yung W.H. 5-HT excites globus pallidus neurons by multiple receptor mechanisms. Neuroscience 151 (2008) 439-451
6. 2C receptor protein in the rat CNS. Neuropharmacology 39 (2000) 123-132
7. 2C receptors. Trends Pharmacol. Sci. 22 (2001) 502-503
8. De Deurwaerdère P., and Chesselet M.-F. Nigrostriatal lesions alter orofacial dyskinesia and c-fos expression induced by the serotonin agonist 1-(m-cholophenyl)piperazine in adult rats. J. Neurosci. 20 (2000) 5170-5178
9. 2C receptor inhibits in vivo dopamine release in the rat nucleus accumbens and striatum. J. Neurosci. 24 (2004) 3235-3241
10. Di Giovanni G., De Deurwaerdère P., Di Mascio M., Di Matteo V., Esposito E., and Spampinato U. Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience 91 (1999) 587-597
11. Di Giovanni G., Di Matteo V., La Grutta V., and Esposito E. m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors. Neuroscience 103 (2001) 111-116
12. Di Matteo V., Pierucci M., Esposito E., Crescimanno G., Benigno A., and Di Giovanni G. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders. Prog. Brain Res. 172 (2008) 423-463
13. 2C-induced oral dyskinesia. Neuroscience 72 (1996) 117-128
14. 2C receptor messenger RNA in the basal ganglia of adults rats. J. Comp. Neurol. 384 (1997) 233-247
15. 2C receptor knockout mice. Neuropharmacology 57 (2009) 259-267
16. 2C receptor antagonism in the substantia nigra zona reticulata of the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Exp. Neurol. 15 (1998) 35-49
17. Gong L., Kostrzewa R.M., Fuller R.W., and Perry K.W. Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system. J. Pharmacol. Exp. Ther. 261 (1992) 1000-1007
18. Invernizzi R.W., Pierucci M., Calcagno E., Di Giovanni G., Di Matteo V., Benigno A., and Esposito E. Selective activation of 5-HT(2C) receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study. Neuroscience 144 (2007) 1523-1535
19. Javed A., Van de Kar L.D., and Gray T.S. The 5-HT1A and 5-HT2A/2C receptor antagonists WAY-100635 and ritanserin do not attenuate D-fenfluramine-induced fos expression in the brain. Brain Res. 791 (1998) 67-74
20. Leslie R.A., Moorman J.M., Coulson A., and Grahame-Smith D.G. Serotonin2/1C receptor activation causes a localized expression of the immediate-early gene c-fos in rat brain: evidence for involvement of dorsal raphe nucleus projection fibres. Neuroscience 53 (1993) 457-463
21. Marchese G., Bartholini F., Ruiu S., Casti P., Casu G.L., and Pani L. Ritanserin counteracts both rat vacuous chewing movements and nigro-striatal tyrosine hydroxylase-immunostaining alterations induced by haloperidol. Eur. J. Pharmacol. 483 (2004) 65-69
22. Mengod G., Nguyen H., Le H., Waeber C., Lubbert H., and Palacios J.M. The distribution and cellular localization of the serotonin 1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution. Neuroscience 35 (1990) 577-591
23. Mehta A., Eberle-Wang K., and Chesselet M.F. Increased m-CPP-induced oral dyskinesia after lesion of serotonergic neurons. Pharmacol. Biochem. Behav. 68 (2001) 347-353
24. 2C receptors. J. Neurochem. 99 (2006) 1311-1319
25. 2A receptor affinity. J. Med. Chem. 38 (1995) 28-33
26. Pasqualetti M., Ori M., Castagna M., Marazziti D., Cassano G.B., and Nardi I. Distribution and cellular localization of the serotonin type 2C receptor messenger RNA in human brain. Neuroscience 92 (1999) 601-611
27. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 4th ed. (1998), Academic Press, San Diego, USA
28. Pazos A., Cortés R., and Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res. 346 (1985) 231-249
29. Rouillard C., Bovetto S., Gervais J., and Richard D. Fenfluramine-induced activation of the immediate-early gene c-fos in the striatum: possible interaction between serotonin and dopamine. Mol. Brain Res. 37 (1996) 105-115
30. 2C receptor mutant mice. Naunyn Schmiedebergs Arch. Pharmacol. 361 (2000) 484-491
31. Stark J.A., Davies K.E., Williams S.R., and Luckman S.M. Functional magnetic resonance imaging and c-Fos mapping in rats following an anorectic dose of m-chlorophenylpiperazine. Neuroimage 31 (2006) 1228-1237
32. Stark J.A., McKie S., Davies K.E., Williams S.R., and Luckman S.M. 5-HT(2C) antagonism blocks blood oxygen level-dependent pharmacological-challenge magnetic resonance imaging signal in rat brain areas related to feeding. Eur. J. Neurosci. 27 (2008) 457-465
33. Stewart B.R., Jenner P., and Marsden C.D. Induction of purposeless chewing behavior in rats by 5-HT agonists drugs. Eur. J. Pharmacol. 162 (1989) 101-107
34. 2C serotonin receptors. Nature 374 (1995) 542-546
35. Trent F., and Tepper J.M. Dorsal raphé stimulation modifies striatal-evoked antidromic invasion of nigral dopaminergic neurons in vivo. Exp. Brain Res. 84 (1991) 620-630
36. 2C receptor signaling is associated with haloperidol-induced "early onset" vacuous chewing in rats: implications for antipsychotic drug therapy. Psychopharmacology (Berl) 182 (2005) 84-94
37. 2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety. Neuropharmacology 41 (2001) 186-199
38. Xiang Z., Wang L., and Kitai S.T. Modulation of spontaneous firing in rat subthalamic neurons by 5-HT receptor subtypes. J. Neurophysiol. 93 (2005) 1145-1157
39. 2C receptor activation in 6-hydroxydopamine-lesioned rats. Brain Res. 1256 (2009) 180-189